MarketRippa logo MarketRippa

1 April 2026 - Top Stories

Coverage across health, digital health, funding, and policy developments in Australia.

Daily digest

17 articles

Methodology: This digest condenses the source coverage listed below for faster scanning by Australian health teams. It is not medical advice.

ACT Digital Health Record hits 271k MyDHR accounts, signaling Canberra's push to unify patient data and speed care.

The ACT system has consolidated data across more than 50 legacy platforms, delivering 826,000 results and avoiding about 90,000 unnecessary blood draws, with 33,179 logins per month on average. That scale creates a clear demand for scalable integration, strong privacy controls, and governance tooling from health IT vendors as interoperability becomes essential in public systems.

Value-based pricing moves forward in Australia as price data appears on the Medical Cost Finder, giving patients clearer cost signals while pressuring providers to align charges with outcomes. This approach hinges on high-quality cost and outcome data; without it, pricing signals distort care decisions and undermine value. Health tech teams should build robust data pipelines and governance to support value measurement.

Medicare Mental Health Check-In LiCBT launches as a free telehealth service for Australians aged 16 and over experiencing mild distress, backed by an eight-year, $588.5 million funding commitment and aiming for about 150,000 users annually. The scale will prompt primary care to align triage, data sharing, and referral workflows with digital mental health support, driving demand for interoperable data flows and secure telehealth platforms.

TGA has granted provisional Wegovy approval to treat metabolic dysfunction associated steatohepatitis in adults with moderate to advanced fibrosis (F2 to F3), enabling GPs to prescribe semaglutide for this use once PBS listing is secured; affordability remains a practical barrier until subsidy coverage is in place. The decision broadens liver disease management in primary care but real-world uptake will depend on price and coverage.

Victoria's reforms on independent pharmacy prescribing proceed, widening access to medicines through pharmacies while requiring robust safety guardrails and clinical decision support to protect patients. The sector will need strong audit trails and integration with patient records to prevent unsafe stock or misprescribing, and RACGP has urged safeguards to ensure pricing and prescribing data remain clinically contextual.

  • ACT Government expanded MyDHR adoption to 271,000 active accounts, accelerating data interoperability across Canberra.
  • Value-based pricing moves forward in Australia as price data appears on the Medical Cost Finder, giving patients clearer cost signals while pressuring providers to align charges with outcomes.
  • Medicare Mental Health Check-In LiCBT launches as a free telehealth service for 16 plus with an eight year, 588.5 million funding commitment, challenging primary care to integrate new care pathways.
  • TGA grants provisional Wegovy approval to treat MASH in adults with F2-F3 fibrosis, enabling GP prescribing before PBS listing but leaving affordability as a practical barrier until subsidy coverage is secured.
  • Victoria's independent pharmacy prescribing reforms proceed, widening access to medicines while requiring strong safety guardrails and decision support to protect patients.